Global Ablation Catheters Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Multielectrode Ablation Catheters and Single Point Ablation Catheters), By Technology (Radiofrequency (RF) Ablation, Cryoablation, and Pulse Field Ablation), By End Use (Hospitals, Ambulatory Surgical Centers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare

RELEASE DATE Aug 2025
REPORT ID SI14790
PAGES 190
REPORT FORMAT PathSoft

Global Ablation Catheters Market Insights Forecasts to 2035

  • The Global Ablation Catheters Market Size Was Estimated at USD 5.2 Billion in 2024
  • The Market Size is Expected to Grow at a CAGR of around 13.28% from 2025 to 2035
  • The Worldwide Ablation Catheters Market Size is Expected to Reach USD 20.5 Billion by 2035
  • Asia Pacific is expected to grow the fastest during the forecast period.

Global Ablation Catheters Market

Get more details on this report -

Request Free Sample PDF

The global ablation catheters market size was worth around USD 5.2 billion in 2024 and is predicted to grow to around USD 20.5 billion by 2035 with a compound annual growth rate (CAGR) of 13.28% from 2025 to 2035. The growing prevalence of cardiac disorders, demand for advanced treatment, and adoption of minimally invasive procedures are driving the ablation catheters market globally.  

 

Market Overview

The ablation catheters market is an industry emphasizing the development, manufacturing, and sale of catheters designed for cardiac ablation procedures. Catheter ablation is a procedure that uses radiofrequency energy (similar to microwave heat) to destroy a small area of heart tissue that is causing a rapid and irregular rhythm. The ablation catheters market is influenced by technological advancement, including the evolution of sophisticated ablation catheters, like high-resolution mapping systems and precision-focused ablation technologies that aid in elevating the precision and efficacy of diagnostic and therapeutic procedures. Innovation in catheter design, materials, and techniques includes the development of irrigated radiofrequency catheters for better thermal regulation and advanced medical technologies for enhancing the precision of catheter placements. With the evolving surgical techniques and technologies, minimally invasive techniques are expanding to promote faster recovery and less disruption to patients' lives. Integration of digital technology, including telerobotic surgery, with the advancement in telecommunications, internet infrastructure, and surgical robotics, is providing a market growth opportunity.

 

Report Coverage

This research report categorizes the ablation catheters market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the ablation catheters market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the ablation catheters market.

 

Ablation Catheters Market Report Coverage

Report CoverageDetails
Base Year:2024
Market Size in 2024:USD 5.2 Billion
Forecast Period:2025-2035
Forecast Period CAGR 2025-2035 :13.28%
2035 Value Projection:USD 20.5 Billion
Historical Data for:2020-2023
No. of Pages:190
Tables, Charts & Figures:126
Segments covered:By Product Type, By Technology, By End Use, By Region and COVID-19 Impact Analysis
Companies covered:: Abbott, AngioDynamics, Boston Scientific Corporation, JnJ (Biosense Webster), Medtronic, Johnson & Johnson, Biotronik SE & Co. KG, Imricor, CardioFocus, MicroPort Scientific Corporation, Stryker, Others.
Pitfalls & Challenges:COVID-19 Empact,Challenges, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The increasing prevalence of cardiac disorders is anticipated to drive the demand for ablation catheters in order to treat heart rhythm disorders by destroying small areas of heart tissue that are responsible for abnormal electrical signals. It was estimated that around 1 in 12 people suffer from heart and circulatory diseases. The most common cardiovascular conditions are coronary (ischaemic) heart disease (global prevalence estimated at 250 million in 2021), peripheral arterial (vascular) disease (110 million), stroke (94 million), and atrial fibrillation (53 million). Further, the demand for advanced treatment and minimally invasive procedures is propelling the ablation catheters market. Advancements in ablation catheter design, including the introduction of radiofrequency and cryoablation catheters, are propelling the market growth.

 

Restraining Factors

The complications associated with the use of ablation catheters, including cardiac perforation or thromboembolism, are challenging the market. Further, the increased cost and stringent regulatory policies may hamper the market growth.

 

Market Segmentation

The ablation catheters market share is classified into product type, technology, and end use.

 

  • The multielectrode ablation catheters segment dominated the market with the largest revenue share in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the product type, the ablation catheters market is divided into multielectrode ablation catheters and single point ablation catheters. Among these, the multielectrode ablation catheters segment dominated the market with the largest revenue share in 2024 and is projected to grow at a substantial CAGR during the forecast period. Multielectrode ablation catheters consist of multiple electrodes that can be flexibly manipulated and positioned at different locations as per the cardiac ablation treatments' adaptability. The efficacy of multielectrode ablation catheters is advantageous to high-volume electrophysiology laboratories, which are propelling the market.

 

  • The radiofrequency (RF) ablation segment accounted for the largest revenue share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the technology, the ablation catheters market is divided into radiofrequency (RF) ablation, cryoablation, and pulse field ablation. Among these, the radiofrequency (RF) ablation segment accounted for the largest revenue share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. It includes the adoption of high-frequency current (500-750Hz) to produce lesions through the process of thermal injury. The demonstrated safety profile and repeatable clinical results of radiofrequency ablation make it a gold standard device for cardiac rhythm management.

 

  • The hospitals segment accounted for the dominant market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end use, the ablation catheters market is divided into hospitals, ambulatory surgical centers, and others. Among these, the hospitals segment accounted for the dominant market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. An increasing focus on providing well-facilitated cardiac care centers in hospitals is anticipated to drive the ablation catheters market.

 

Regional Segment Analysis of the Ablation Catheters Market

  • North America (U.S., Canada, Mexico) 
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Rest of APAC)
  • South America (Brazil and the Rest of South America) 
  • The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the largest share of the ablation catheters market over the predicted timeframe.

 

Global Ablation Catheters Market

Get more details on this report -

Request Free Sample PDF

North America is anticipated to hold the largest share of the ablation catheters market over the predicted timeframe. Advancements in catheter technology, along with the rising prevalence of cardiovascular diseases, including atrial fibrillation and ventricular tachycardia, are propelling the market growth. Further, the presence of well-established healthcare systems and comprehensive insurance coverage is contributing to driving the market of ablation catheters.

 

Asia Pacific is expected to grow at a rapid CAGR in the ablation catheters market during the forecast period. The increased need for innovative and effective ablation therapies, with an increasing awareness about advanced cardiac treatments, is propelling the market growth. The region’s growing prevalence of chronic diseases, with the emergence of next-generation ablation products & technology, is responsible for driving the market.

 

Europe is anticipated to hold a substantial share of the ablation catheters market during the predicted timeframe. The increasing preference for minimally invasive ablation catheters over traditional interventions is contributing to driving the market. Further, the adoption of advanced technologies, including 3D mapping systems and robotic-assisted surgery, is bolstering the market growth.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the ablation catheters market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Abbott
  • AngioDynamics
  • Boston Scientific Corporation
  • JnJ (Biosense Webster)
  • Medtronic
  • Johnson & Johnson
  • Biotronik SE & Co. KG
  • Imricor
  • CardioFocus
  • MicroPort Scientific Corporation
  • Stryker
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting And Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs) 

 

Recent Development

  • In October 2024, Boston Scientific announced that it received FDA approval for its navigation-enabled Faeawave Nav ablation catheter and clearance for new Faraview software.
  • In October 2024, Medtronic plc, a global leader in healthcare technology, announced USFDA approval of the Affera Mapping and Ablation System with Sphere 9 Catheter, an all-in-one, high-density (HD) mapping and pulsed field (PF) and radiofrequency (RF) ablation catheter for treatment of persistent atrial fibrillation (AFib) and RF ablation of cavotricuspid isthmus (CTI) dependent atrial flutter.
  • In March 2024, Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announced the submission of the VARIPULSE Platform for premarket approval application (PMA) to the USFDA.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the ablation catheters market based on the below-mentioned segments:

 

Global Ablation Catheters Market, By Product Type

  • Multielectrode Ablation Catheters
  • Single Point Ablation Catheters

 

Global Ablation Catheters Market, By Technology

  • Radiofrequency (RF) Ablation
  • Cryoablation
  • Pulse Field Ablation

 

Global Ablation Catheters Market, By End Use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

 

Global Ablation Catheters Market, By Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Frequently Asked Questions (FAQ)

  • 1. What is the CAGR of the ablation catheters market over the forecast period?
    The global ablation catheters market is projected to expand at a CAGR of 13.28% during the forecast period.
  • 2. What is the market size of the ablation catheters market?
    The global ablation catheters market size is expected to grow from USD 5.2 Billion in 2024 to USD 20.5 Billion by 2035, at a CAGR of 13.28% during the forecast period 2025-2035.
  • 3. Which region holds the largest share of the ablation catheters market?
    North America is anticipated to hold the largest share of the ablation catheters market over the predicted timeframe.

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies